InsurTech SPACs face nail-biting redemption votes
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Free Trial
  • Log in

InsurTech SPACs face nail-biting redemption votes

Bernard Goyder
June 01, 2021
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
Hippo qomplx doma logos NYC 2.jpg

A trio of InsurTech special purpose acquisition company (SPAC) deals now face the prospect of investor redemptions, as a crucial equity market indicator points to muted support for the transactions among investors.

Hippo, Doma and Qomplx all agreed to merge with SPACs in early March, at a time when institutional investors were enthusiastically backing such deals at pumped up valuations.

Subscribers, log in here:

Fuel a smarter strategy with our actionable market intelligence

      • Gain a competitive edge and accelerate decision-making
      • Be empowered by insights that transform confusion to clarity
      • Uncover growth opportunities and prepare for potential threats
      • Fuel a smarter strategy for business growth
Request a free trial Already a subscriber? Log in now

Topics

News Personal lines InsurTech SPACs Metromile Hippo Root Lemonade
BG
Bernard Goyder
Gift this article